Attorney General Raúl Labrador announced a multistate settlement in principle with pharmaceutical company Mylan Inc. on April 8, 2025. The agreement will facilitate the distribution of up to $335 million nationwide to tackle the opioid crisis. Mylan, which is currently part of Viatris, has been involved in manufacturing and selling opioids such as generic fentanyl patches, oxycodone, hydrocodone, and buprenorphine since 2005.
The attorneys general claim that Mylan misleadingly marketed its products as less prone to abuse, despite being aware that certain opioids, especially its fentanyl patches, were more susceptible to abuse. Mylan allegedly exacerbated the opioid crisis by promoting these products directly to doctors, resulting in excessive prescribing and diversion into illegal markets.
“Those responsible for fueling the opioid crisis are finally being held to account for their greed-driven actions,” Labrador stated. He added, “These settlements will never put those lost lives and broken families back together, but hopefully we can avoid the wreckage of future addiction with wisely targeted investments in prevention and treatment throughout Idaho.”
The settlement mandates that Mylan will provide up to $335 million to participating states over a period of nine years. The negotiations included the attorney generals from California, Illinois, Massachusetts, New York, North Carolina, Oregon, Tennessee, Utah, Virginia, Colorado, Delaware, Georgia, Idaho, Iowa, and Vermont.